logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (iv) All cannabis inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium5.85.114.774.415613
Bulgaria::33.366.730
Czech Republic13.717.426.642.324121
Denmark:4.823.871.4638
Germany17.421.234.926.62263:
Estonia::::::
Ireland118.93.540.337.431842
Greece14.914.923.446.8940
Spain::::::
France2.810.214.872.21085
Italy::::::
Cyprus34.425.012.528.1320
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary3.621.432.142.9560
Malta::::::
Netherlands8.50.95.685461240
Austria33.312.725.428.6638
Poland218.614.129.937.317710
Portugal::::::
Romania14.629.220.835.44829
Slovenia::::::
Slovakia7.814.835.741.71158
Finland28.014.038.020.0501
Sweden117.78.222.651.532823
United Kingdom3::::::
Croatia48.020.012.020.02535
Turkey4.010.612.373.135013
Norway15.511.614.9581818
Total14.814.727.143.44951456
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013